Gilead Sciences (GILD) Cash from Investing Activities (2009 - 2026)
Gilead Sciences (GILD) reported Cash from Investing Activities of -$244 million for Q3 2026, compared with -$427 million a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Gilead Sciences' Cash from Investing Activities came in at -$10.66 billion; for FY2025, it came in at -$4.79 billion.
- By year, Cash from Investing Activities came in at -$3.45 billion in FY2024, -$2.27 billion in FY2023, -$2.47 billion in FY2022 and -$3.13 billion in FY2021.
- Five-year quarterly Cash from Investing Activities spans a low of -$10.35 billion in Q2 2026 and a high of $1.77 billion in Q1 2026.
- Per Business Quant data, the three quarters before Q3 2026 came in at -$10.35 billion (Q2 2026), $1.77 billion (Q1 2026) and -$1.84 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | -8.30 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | -2.71 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | -10.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | -1.32 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -1.89 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | -649.00 Mn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -244.00 Mn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | -2.03 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | -6.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -244.00 Mn |
| Jun 30, 2026 | -10.35 Bn |
| Mar 31, 2026 | 1.77 Bn |
| Dec 31, 2025 | -1.84 Bn |
| Sep 30, 2025 | -427.00 Mn |
| Jun 30, 2025 | -2.12 Bn |
| Mar 31, 2025 | -415.00 Mn |
| Dec 31, 2024 | -225.00 Mn |
| Sep 30, 2024 | -710.00 Mn |
| Jun 30, 2024 | -307.00 Mn |
| Mar 31, 2024 | -2.21 Bn |
| Dec 31, 2023 | -727.00 Mn |
| Sep 30, 2023 | -229.00 Mn |
| Jun 30, 2023 | -483.00 Mn |
| Mar 31, 2023 | -826.00 Mn |
| Dec 31, 2022 | -375.00 Mn |
| Sep 30, 2022 | -713.00 Mn |
| Jun 30, 2022 | -308.00 Mn |
| Mar 31, 2022 | -1.07 Bn |
| Dec 31, 2021 | -278.00 Mn |
API Access
Gilead Sciences Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();